BeStock  

AstraZeneca AZN

US equityMarket cap rank #49Infectious Disease
$186.43 −$0.42 (-0.22%)
Market closed · Nov 6, 8:10 pm ET · Last extended-hours $185.92 -0.27%
Open$181.34
Prev close$186.85
Day range$181.20 – $187.33
Volume2.85M
Market cap$289.14B
P/E (TTM)26.4
Dividend yield1.73%

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership74.5%-0.46 pts vs. prior quarter
Institutions holding2,228-52 vs. prior quarter
Insider trades (recent)7 buys / 2 sellsNet buying
Short interest0.21% of floatDays to cover 1.1 · as of 15 Oct 2026
Short-sale volume share17.8%5-day average of daily volume

Short-sale volume as % of daily volume

8%14%21%27%Sep '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$37.78M (12 inflow days, 8 outflow days).

Net flow by order size, last 20 sessions

+$20.4MSuper+$17.4MBig+$33.9MMid+$4.0MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 22.8% of shares outstanding.

Largest holders

  • BlackRock8.85%
  • Capital Research4.68%
  • Vanguard Capital Management, LLC3.78%
  • Investor AB (publ)3.33%
  • Norges Bank Investment Management2.18%
  • Wellington Management Group1.84%
  • Legal & General Investment Management1.66%
  • FMR1.58%

By investor type

  • Mutual Fund57.26%
  • Sovereign Wealth Fund3.76%
  • VC/PE Fund3.65%
  • Public Company3.38%
  • Private Company3.06%
  • Government Pension Fund1.97%
  • Hedge Fund0.68%
  • Corporate Pension Plan0.23%

Reported short interest has risen from 0.12% to 0.21% of float over the last 6 biweekly reports (31 Jul 2026 to 15 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Parnassus Investments Mutual Fund 2026/Q3 +2,135,690 0.2%
Assenagon Asset Management S.A. Mutual Fund 2026/Q3 +1,308,232 0.2%
Wellington Management Group Mutual Fund 2026/Q3 +4,786,158 1.8%
Neuberger Berman Investment Advisers LLC Mutual Fund 2026/Q3 +2,645,090 0.2%
Brewin Dolphin Wealth Management Limited Mutual Fund 2026/Q3 +1,994,870 0.1%
Causeway Capital Management LLC Mutual Fund 2026/Q3 +1,935,641 0.6%
Aegon Asset Management UK Plc Mutual Fund 2026/Q3 +1,905,200 0.1%
Amundi Asset Management Mutual Fund 2026/Q3 +1,779,984 1.2%
Capital Research Mutual Fund 2026/Q3 +1,599,804 4.7%
Norges Bank Investment Management Sovereign Wealth Fund 2026/Q3 +1,528,010 2.2%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +1,412,106 0.2%
Citigroup Inc. Public Company 2026/Q3 +1,190,281 0.3%
Boston Partners Global Investors, Inc. Mutual Fund 2026/Q3 +1,083,731 0.2%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q3 +1,069,588 0.1%
Morgan Stanley Public Company 2026/Q3 +822,700 0.3%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
5 Oct 2026 Mani Sharma Other Acquisition +2 $159.80 19,291
7 Sep 2026 Mani Sharma Other Acquisition +1 $162.60 19,289
7 Aug 2026 Mani Sharma Private Acquisition +20 $160.57 19,289
5 Aug 2026 Mani Sharma Other Acquisition +2 $163.34 19,267
5 Jul 2026 Mani Sharma Other Acquisition +2 $190.43 19,265
7 Jun 2026 Mani Sharma Other Acquisition +1 $179.75 19,263
19 May 2026 Mani Sharma Private Disposition -11,893 $185.78 19,262
5 May 2026 Mani Sharma Other Acquisition +2 $196.03 31,155
17 Mar 2026 Mani Sharma Initial Statement of Beneficial +0 – 2,996
11 Nov 2025 Aradhana Sarin Chief Financial Officer Intent to Sell (Form 144) -15,000 $88.88 –

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Oct 2026 3,284,132 0.2% 1.1
30 Sep 2026 2,618,811 0.2% 1.0
15 Sep 2026 2,087,754 0.1% 1.0
31 Aug 2026 2,895,178 0.2% 1.0
14 Aug 2026 1,892,646 0.1% 1.0
31 Jul 2026 1,838,477 0.1% 1.0

Discussion

No comments yet — be the first to weigh in on AZN.

Sign in to join the discussion.

Scroll to Top